Novartis AG (NVS)
97.11
+0.34
(+0.35%)
USD |
NYSE |
Dec 20, 16:00
97.08
-0.02
(-0.03%)
After-Hours: 20:00
Novartis Shareholders Equity (Quarterly): 43.32B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 14.24B |
| Pfizer Inc | 92.29B |
| PTC Therapeutics Inc | -1.054B |
| Monte Rosa Therapeutics Inc | 205.46M |
| AstraZeneca PLC | 40.72B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 103.52B |
| Total Liabilities (Quarterly) | 60.08B |
| Debt to Equity Ratio | 0.6999 |
| Current Ratio | 1.111 |
| Net Debt Paydown Yield | -0.33% |